Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Nov;110(3):1156–1164. doi: 10.1111/j.1476-5381.1993.tb13935.x

Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium.

W Feniuk 1, J Dimech 1, P P Humphrey 1
PMCID: PMC2175805  PMID: 7905341

Abstract

1. Somatostatin14 (SS14) inhibits neurogenically mediated contractile responses in guinea-pig ileum and vas deferens and exerts a direct negative inotropic action in guinea-pig spontaneously beating right atrium. In this study, the receptors mediating these inhibitory effects have been characterized by comparing the potencies of several cyclic somatostatin analogues. 2. In the guinea-pig ileum, SS14, somatostatin28 (SS28), somatostatin25 (SS25) and several smaller cyclic somatostatin analogues including octreotide, angiopeptin and CGP 23996, inhibited neurogenically mediated contractile responses, each being of similar potency. 3. In contrast, in the guinea-pig vas deferens and right atrium, SS28 was about 30 times more potent than SS14. However, although angiopeptin was nearly as potent as SS14 as an agonist in the vas deferens, in guinea-pig atrium angiopeptin had low intrinsic activity and antagonized the negative inotropic action of both SS14 and SS28 (pKB values of 7.4 and 7.2, respectively). CGP 23996 was 2-7 times weaker than SS14 in guinea-pig vas deferens and atria. 4. Phosphoramidon (1 microM) and amastatin (10 microM) did not influence the potency of SS14 or SS28 in either the guinea-pig ileum or right atrium. In the guinea-pig vas deferens, phosphoramidon and amastatin did not affect the potency of SS28, but enhanced the potency of SS14 about 5 fold. Despite the presence of phosphoramidon and amastatin, SS28 was still more potent than SS14 in the vas deferens. 5. The putative somatostatin receptor blocking drug, cyclo(7-aminoheptanoyl Phe-D-Trp-Lys-Thr[Brl]) (CPP; 1 microM), did not antagonize the effects of either SS14 or SS28 in ileum, vas deferens or atrial preparations.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Araujo D. M., Lapchak P. A., Collier B., Quirion R. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. J Neurochem. 1990 Nov;55(5):1546–1555. doi: 10.1111/j.1471-4159.1990.tb04937.x. [DOI] [PubMed] [Google Scholar]
  3. Bell G. I., Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci. 1993 Jan;16(1):34–38. doi: 10.1016/0166-2236(93)90050-v. [DOI] [PubMed] [Google Scholar]
  4. Brazeau P., Ling N., Esch F., Böhlen P., Benoit R., Guillemin R. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regul Pept. 1981 Jan;1(4):255–264. doi: 10.1016/0167-0115(81)90048-3. [DOI] [PubMed] [Google Scholar]
  5. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  6. Bruno J. F., Xu Y., Song J., Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11151–11155. doi: 10.1073/pnas.89.23.11151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohen M. L., Rosing E., Wiley K. S., Slater I. H. Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle. Life Sci. 1978 Oct 23;23(16):1659–1664. doi: 10.1016/0024-3205(78)90463-0. [DOI] [PubMed] [Google Scholar]
  8. Dimech J., Feniuk W., Humphrey P. P. Antagonist effects of seglitide (MK 678) at somatostatin receptors in guinea-pig isolated right atria. Br J Pharmacol. 1993 Aug;109(4):898–899. doi: 10.1111/j.1476-5381.1993.tb13703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Endou M., Hattori Y., Nakaya H., Kanno M. Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein. J Pharmacol Exp Ther. 1989 Aug;250(2):726–733. [PubMed] [Google Scholar]
  10. Fries J. L., Murphy W. A., Sueiras-Diaz J., Coy D. H. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat. Peptides. 1982 Sep-Oct;3(5):811–814. doi: 10.1016/0196-9781(82)90020-1. [DOI] [PubMed] [Google Scholar]
  11. Furness J. B., Costa M. Actions of somatostatin on excitatory and inhibitory nerves in the intestine. Eur J Pharmacol. 1979 Jun;56(1-2):69–74. doi: 10.1016/0014-2999(79)90434-5. [DOI] [PubMed] [Google Scholar]
  12. Gu Z. F., Pradhan T., Coy D. H., Mantey S., Bunnett N. W., Jensen R. T., Maton P. N. Actions of somatostatins on gastric smooth muscle cells. Am J Physiol. 1992 Mar;262(3 Pt 1):G432–G438. doi: 10.1152/ajpgi.1992.262.3.G432. [DOI] [PubMed] [Google Scholar]
  13. Hirst B. H., Conlon J. M., Coy D. H., Holland J., Shaw B. Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats. Regul Pept. 1982 Sep;4(4):227–237. doi: 10.1016/0167-0115(82)90115-x. [DOI] [PubMed] [Google Scholar]
  14. Magnan J., Regoli D., Quirion R., Lemaire S., St-Pierre S., Rioux F. Studies on the inhibitory action of somatostatin in the electrically stimulated rat vas deferens. Eur J Pharmacol. 1979 May 15;55(4):347–354. doi: 10.1016/0014-2999(79)90108-0. [DOI] [PubMed] [Google Scholar]
  15. McIntosh C. H., Bakich V., Kwok Y. N., Brown J. C. A comparison of the inhibitory effects of somatostatin-14, -25, and -28 on motility of the guinea pig ileum. Can J Physiol Pharmacol. 1986 Mar;64(3):303–306. doi: 10.1139/y86-048. [DOI] [PubMed] [Google Scholar]
  16. Meyers C. A., Murphy W. A., Redding T. W., Coy D. H., Schally A. V. Synthesis and biological actions of prosomatostatin. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6171–6174. doi: 10.1073/pnas.77.10.6171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. O'Carroll A. M., Lolait S. J., König M., Mahan L. C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol. 1992 Dec;42(6):939–946. [PubMed] [Google Scholar]
  18. Ohmura T., Nishio M., Kigoshi S., Muramatsu I. Somatostatin decreases the calcium inward current in guinea-pig atria. Br J Pharmacol. 1990 Mar;99(3):587–591. doi: 10.1111/j.1476-5381.1990.tb12973.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Priestley T., Woodruff G. N. The inhibitory effect of somatostatin peptides on the rat anococcygeus muscle in vitro. Br J Pharmacol. 1988 May;94(1):87–96. doi: 10.1111/j.1476-5381.1988.tb11502.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Quirion R., Regoli D., Rioux F., St-Pierre S. An analysis of the negative inotropic action of somatostatin. Br J Pharmacol. 1979 Jun;66(2):251–257. doi: 10.1111/j.1476-5381.1979.tb13673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Raynor K., Reisine T. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. J Pharmacol Exp Ther. 1989 Nov;251(2):510–517. [PubMed] [Google Scholar]
  22. Raynor K., Reisine T. Differential coupling of somatostatin1 receptors to adenylyl cyclase in the rat striatum vs. the pituitary and other regions of the rat brain. J Pharmacol Exp Ther. 1992 Feb;260(2):841–848. [PubMed] [Google Scholar]
  23. Rens-Domiano S., Law S. F., Yamada Y., Seino S., Bell G. I., Reisine T. Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol. 1992 Jul;42(1):28–34. [PubMed] [Google Scholar]
  24. Richards M. H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem Pharmacol. 1991 Oct 9;42(9):1645–1653. doi: 10.1016/0006-2952(91)90498-t. [DOI] [PubMed] [Google Scholar]
  25. Sneddon P., Burnstock G. Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol. 1984 Apr 13;100(1):85–90. doi: 10.1016/0014-2999(84)90318-2. [DOI] [PubMed] [Google Scholar]
  26. Takeda T., Taniyama K., Baba S., Tanaka C. Putative mechanisms involved in excitatory and inhibitory effects of somatostatin on intestinal motility. Am J Physiol. 1989 Oct;257(4 Pt 1):G532–G538. doi: 10.1152/ajpgi.1989.257.4.G532. [DOI] [PubMed] [Google Scholar]
  27. Teitelbaum D. H., O'Dorisio T. M., Perkins W. E., Gaginella T. S. Somatostatin modulation of peptide-induced acetylcholine release in guinea pig ileum. Am J Physiol. 1984 May;246(5 Pt 1):G509–G514. doi: 10.1152/ajpgi.1984.246.5.G509. [DOI] [PubMed] [Google Scholar]
  28. Terenius L. Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors. Eur J Pharmacol. 1976 Jul;38(1):211–213. doi: 10.1016/0014-2999(76)90221-1. [DOI] [PubMed] [Google Scholar]
  29. Tran V. T., Beal M. F., Martin J. B. Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science. 1985 Apr 26;228(4698):492–495. doi: 10.1126/science.2858917. [DOI] [PubMed] [Google Scholar]
  30. Yasuda K., Rens-Domiano S., Breder C. D., Law S. F., Saper C. B., Reisine T., Bell G. I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J Biol Chem. 1992 Oct 5;267(28):20422–20428. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES